glp 1 microdose noom GLP-1 Microdosing Reshapes Weight Loss Noom Launches GLP-1 Microdosing for

International Journal of Cosmetic Science, 2005

What started as a class of medications for type 2 diabetes moved into weight loss, and has since expanded into treating fatty liver disease (also known as metabolic dysfunction-associated steatohepatitis, or MASH), specific cardiovascular diseases, obstructive sleep apnea, and the list continues to grow

Life Extension - Why We Do It

For many people, peptide therapy is not a magic shortcut but one part of a broader strategy to heal, stabilize, and move through aging with more confidence and control

Understanding how it works is the first step in deciding if its the right path for your personal health goals